-
NIP51mRNA670_PP2AmRNA570_(6)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(11)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(2)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(1)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(5)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
Characteristics of study subjects.
JA-1, first-generation Japanese-Americans; JA-2, second- or later-generation Japanese-Americans; BMI, body mass index; BP, blood pressure; 2-h, two-hour post-load; HOMA-IR,... -
NIP51mRNA670_PP2AmRNA570_(4)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(8)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(12)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(13)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(3)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(10)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
NIP51mRNA670_PP2AmRNA570_(7)
NIP5;1 mRNA (exon) probes (Quasar 670, channel 1), PP2A mRNA (exon) probes (Quasar 570, channel 2) and DAPI, channel 3. -
Characteristics of included studies.
RCT: Randomised controlled trial. GS: Gilead Sciences. R: Roche. GSK: GlaxoSmithKline. NS: not stated. aCopies/mL converted to IU/mL by dividing by 5.bThe limit of detection of...